Jennifer Burstein - Net Worth and Insider Trading

Jennifer Burstein Net Worth

The estimated net worth of Jennifer Burstein is at least $0 dollars as of 2024-04-29. Jennifer Burstein is the Senior VP of Finance of Loxo Oncology Inc and owns about 0 shares of Loxo Oncology Inc (LOXO) stock worth over $0. Details can be seen in Jennifer Burstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jennifer Burstein has not made any transactions after 2018-12-11 and currently still holds the listed stock(s).

Transaction Summary of Jennifer Burstein

To

Jennifer Burstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jennifer Burstein owns 2 companies in total, including Stoke Therapeutics Inc (STOK) , and Loxo Oncology Inc (LOXO) .

Click here to see the complete history of Jennifer Burstein’s form 4 insider trades.

Insider Ownership Summary of Jennifer Burstein

Ticker Comapny Transaction Date Type of Owner
STOK Stoke Therapeutics Inc 2020-06-03 director
LOXO Loxo Oncology Inc 2019-02-15 Senior VP of Finance

Jennifer Burstein Latest Holdings Summary

Jennifer Burstein currently owns a total of 1 stock. Jennifer Burstein owns 0 shares of Loxo Oncology Inc (LOXO) as of December 11, 2018, with a value of $0.

Latest Holdings of Jennifer Burstein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LOXO Loxo Oncology Inc 2018-12-11 0 234.66 0

Holding Weightings of Jennifer Burstein


Jennifer Burstein Form 4 Trading Tracker

According to the SEC Form 4 filings, Jennifer Burstein has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 2,500 shares on December 11, 2018, which brought Jennifer Burstein around $338,875.

Insider Trading History of Jennifer Burstein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jennifer Burstein Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jennifer Burstein Ownership Network

Ownership Network List of Jennifer Burstein

No Data

Ownership Network Relation of Jennifer Burstein


Jennifer Burstein Owned Company Details

What does Stoke Therapeutics Inc do?

Who are the key executives at Stoke Therapeutics Inc?

Jennifer Burstein is the director of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include 10 percent owner Skorpios Trust , General Counsel & Corp Sec Jonathan Allan , and director & CEO Kaye Edward M. Md .

Stoke Therapeutics Inc (STOK) Insider Trades Summary

Over the past 18 months, Jennifer Burstein made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 139,116 shares made by Barry Ticho , a net sale of 9,423 shares made by Jonathan Allan , and a net sale of 3,600,000 shares made by Skorpios Trust .

In summary, during the past 3 months, insiders sold 3,650,973 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 3,650,973 shares. During the past 18 months, 3,767,921 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,767,921 shares.

Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Stoke Therapeutics Inc Insider Transactions

No Available Data

Jennifer Burstein Mailing Address

Above is the net worth, insider trading, and ownership report for Jennifer Burstein. You might contact Jennifer Burstein via mailing address: C/o Loxo Oncology, Inc., One Landmark Square, Suite 1122, Stamford Ct 06901.

Discussions on Jennifer Burstein

No discussions yet.